Emerging insulin therapies for diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1298, 2001-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Therapies and Emerging Targets for the Treatment of Diabetes

By  

Current Pharmaceutical Design, Vol. 7, Iss. 6, 2001-04 ,pp. : 417-450

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Insulin Dependent Diabetes Mellitus: Present Therapies and New Drug Targets#

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-11 ,pp. : 1019-1034

Bentham Science Publishers

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert   Hagan Michael A.  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Emerging therapies for gout

By Singh Jasvinder A  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 511-518

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies for rheumatoid arthritis

By Jacques Peggy   Van den Bosch Filip  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 231-244

Informa Healthcare

Access to resources Recommend Favorite